Worth Venture Partners, LLC Esperion Therapeutics, Inc. Call Options Transaction History

Worth Venture Partners, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2018 Aug 13, 2018	SELL	$36.2 - $76.4 $778,300 - $1.64 Million	-21,500 Closed	0 $0
Q1 2018 May 25, 2018	SELL	$65.94 - $80.76 $140 Million - $172 Million	-2,128,500 Reduced 99.0%	21,500 $205,000
Q1 2018 May 11, 2018	BUY	$65.94 - $80.76 $142 Million - $174 Million	2,150,000 New	2,150,000 $205,000

211

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $124M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.